title: Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.
authors.affiliation: Department of Dermatology, Lewisham and Greenwich NHS Trust, London, UK.
authors.forename: T J
authors.initials: TJ
authors.lastname: Tull
authors.affiliation: Department of Respiratory Medicine, Lewisham and Greenwich NHS Trust, London, UK.
authors.forename: T
authors.initials: T
authors.lastname: Toma
authors.affiliation: Department of Dermatology, Lewisham and Greenwich NHS Trust, London, UK.
authors.forename: H P
authors.initials: HP
authors.lastname: Menagé
mesh_terms: D000328:Adult; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging; D008214:Lymphocytes / Q000473:pathology; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction; D020775:Thoracic Surgery, Video-Assisted / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D005938:Glucocorticoids; D011239:Prednisolone; D009173:Mycophenolic Acid